IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice

Journal of Immunology

Volumn 191, Issue 9, 2013, Pages 4581-4588

  McPhee, Caroline G ^a   Bubier, Jason A ^a   Sproule, Thomas J ^a   Park, Giljun ^a   Steinbuck, Martin P ^a,c   Schott, William H ^a   Christianson, Gregory J ^a   Morse III, Herbert C ^b   Roopenian, Derry C ^a  

^a JACKSON LABORATORY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; CYTOKINE; INTERLEUKIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; TARGET CELL; ANIMAL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; GENETICS; IMMUNOLOGY; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; INTERLEUKINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-21; SIGNAL TRANSDUCTION;

EID: 84886049045     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300439     Document Type: Article

References (47)

1. Spolski, R., and W. J. Leonard. 2008. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26: 57-79.
2. Ettinger, R., S. Kuchen, and P. E. Lipsky. 2008. The role of IL-21 in regulating B-cell function in health and disease. Immunol. Rev. 223: 60-86.
3. Odegard, J. M., B. R. Marks, L. D. DiPlacido, A. C. Poholek, D. H. Kono, C. Dong, R. A. Flavell, and J. Craft. 2008. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J. Exp. Med. 205: 2873-2886.
4. Bubier, J. A., T. J. Sproule, O. Foreman, R. Spolski, D. J. Shaffer, H. C. Morse, III, W. J. Leonard, and D. C. Roopenian. 2009. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc. Natl. Acad. Sci. USA 106: 1518-1523.
5. Craft, J. E. 2012. Follicular helper T cells in immunity and systemic autoimmunity. Nat Rev Rheumatol 8: 337-347.
6. Li, J., H. F. Pan, H. Cen, J. Tian, Y. Ma, J. H. Tao, and D. Q. Ye. 2011. Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus. Mol. Biol. Rep. 38: 4077-4081.
7. Nakou, M., E. D. Papadimitraki, A. Fanouriakis, G. K. Bertsias, C. Choulaki, N. Goulidaki, P. Sidiropoulos, and D. T. Boumpas. 2013. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells. Clin. Exp. Rheumatol. 31: 172-179.
8. Yu, D., and C. G. Vinuesa. 2010. Multiple checkpoints keep follicular helper T cells under control to prevent autoimmunity. Cell. Mol. Immunol. 7: 198-203.
9. Sarra, M., and G. Monteleone. 2010. Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus. J. Biomed. Biotechnol. 2010: 294582.
10. Terrier, B., N. Costedoat-Chalumeau, M. Garrido, G. Geri, M. Rosenzwajg, L. Musset, D. Klatzmann, D. Saadoun, and P. Cacoub. 2012. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus. J. Rheumatol. 39: 1819-1828.
11. Monteleone, G., F. Pallone, and T. T. Macdonald. 2009. Interleukin-21 as a new therapeutic target for immune-mediated diseases. Trends Pharmacol. Sci. 30: 441-447.
12. Nguyen, V., I. Luzina, H. Rus, C. Tegla, C. Chen, and V. Rus. 2012. IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms. J. Immunol. 189: 1081-1093.
13. Vogelzang, A., H. M. McGuire, D. Yu, J. Sprent, C. R. Mackay, and C. King. 2008. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29: 127-137.
14. Nurieva, R. I., Y. Chung, D. Hwang, X. O. Yang, H. S. Kang, L. Ma, Y. H. Wang, S. S. Watowich, A. M. Jetten, Q. Tian, and C. Dong. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29: 138-149.
15. Vinuesa, C. G., and J. G. Cyster. 2011. How T cells earn the follicular rite of passage. Immunity 35: 671-680.
16. Attridge, K., C. J. Wang, L. Wardzinski, R. Kenefeck, J. L. Chamberlain, C. Manzotti, M. Kopf, and L. S. Walker. 2012. IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis. Blood 119: 4656-4664.
17. Ozaki, K., R. Spolski, R. Ettinger, H. P. Kim, G. Wang, C. F. Qi, P. Hwu, D. J. Shaffer, S. Akilesh, D. C. Roopenian, et al. 2004. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173: 5361-5371.
18. Ettinger, R., G. P. Sims, A. M. Fairhurst, R. Robbins, Y. S. da Silva, R. Spolski, W. J. Leonard, and P. E. Lipsky. 2005. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175: 7867-7879.
19. Linterman, M. A., L. Beaton, D. Yu, R. R. Ramiscal, M. Srivastava, J. J. Hogan, N. K. Verma, M. J. Smyth, R. J. Rigby, and C. G. Vinuesa. 2010. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207: 353-363.
20. Zotos, D., J. M. Coquet, Y. Zhang, A. Light, K. D'Costa, A. Kallies, L. M. Corcoran, D. I. Godfrey, K. M. Toellner, M. J. Smyth, et al. 2010. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 207: 365-378.
21. Lee, S. K., R. J. Rigby, D. Zotos, L. M. Tsai, S. Kawamoto, J. L. Marshall, R. R. Ramiscal, T. D. Chan, D. Gatto, R. Brink, et al. 2011. B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells. J. Exp. Med. 208: 1377-1388.
22. Bessa, J., M. Kopf, and M. F. Bachmann. 2010. Cutting edge: IL-21 and TLR signaling regulate germinal center responses in a B cell-intrinsic manner. J. Immunol. 184: 4615-4619.
23. Allard, E. L., M. P. Hardy, J. Leignadier, M. Marquis, J. Rooney, D. Lehoux, and N. Labrecque. 2007. Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur. J. Immunol. 37: 3069-3077.
24. Nguyen, H., and N. P. Weng. 2010. IL-21 preferentially enhances IL-15mediated homeostatic proliferation of human CD28+ CD8 memory T cells throughout the adult age span. J. Leukoc. Biol. 87: 43-49.
25. Johnson, L. D., and S. C. Jameson. 2009. Immunology. A chronic need for IL-21. Science 324: 1525-1526.
26. Tagaya, Y. 2010. Editorial: memory CD8 T cells now join "Club 21". J. Leukoc. Biol. 87: 13-15.
27. McPhee, C. G., T. J. Sproule, D. M. Shin, J. A. Bubier, W. H. Schott, M. P. Steinbuck, L. Avenesyan, H. C. Morse, III, and D. C. Roopenian. 2011. MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis. J. Immunol. 187: 4695-4704.
28. Murphy, E. D., and J. B. Roths. 1979. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 22: 1188-1194.
29. Izui, S., N. Ibnou-Zekri, L. Fossati-Jimack, and M. Iwamoto. 2000. Lessons from BXSB and related mouse models. Int. Rev. Immunol. 19: 447-472.
30. Baccala, R., R. Gonzalez-Quintial, R. D. Schreiber, B. R. Lawson, D. H. Kono, and A. N. Theofilopoulos. 2012. Anti-IFN-a/b receptor antibody treatment ameliorates disease in lupus-predisposed mice. J. Immunol. 189: 5976-5984.
31. Pisitkun, P., J. A. Deane, M. J. Difilippantonio, T. Tarasenko, A. B. Satterthwaite, and S. Bolland. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312: 1669-1672.
32. Subramanian, S., K. Tus, Q. Z. Li, A. Wang, X. H. Tian, J. Zhou, C. Liang, G. Bartov, L. D. McDaniel, X. J. Zhou, et al 2006. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103: 9970-9975.
33. Deane, J. A., P. Pisitkun, R. S. Barrett, L. Feigenbaum, T. Town, J. M. Ward, R. A. Flavell, and S. Bolland. 2007. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27: 801-810.
34. Kim, H. J., X. Wang, S. Radfar, T. J. Sproule, D. C. Roopenian, and H. Cantor. 2011. CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc. Natl. Acad. Sci. USA 108: 2010-2015.
35. Wei, L., A. Laurence, K. M. Elias, and J. J. O'Shea. 2007. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 282: 34605-34610.
36. Nurieva, R., X. O. Yang, G. Martinez, Y. Zhang, A. D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S. S. Watowich, A. M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480-483.
37. Bubier, J. A., S. M. Bennett, T. J. Sproule, B. L. Lyons, S. Olland, D. A. Young, and D. C. Roopenian. 2007. Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 1110: 590-601.
38. Kitamura, D., J. Roes, R. Kühn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423-426.
39. Lawson, B. R., S. I. Koundouris, M. Barnhouse, W. Dummer, R. Baccala, D. H. Kono, and A. N. Theofilopoulos. 2001. The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus. J. Immunol. 167: 2354-2360.
40. Roopenian, D. C., G. J. Christianson, T. J. Sproule, A. C. Brown, S. Akilesh, N. Jung, S. Petkova, L. Avanessian, E. Y. Choi, D. J. Shaffer, et al 2003. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J. Immunol. 170: 3528-3533.
41. Christianson, G. J., R. L. Blankenburg, T. M. Duffy, D. Panka, J. B. Roths, A. Marshak-Rothstein, and D. C. Roopenian. 1996. beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice. J. Immunol. 156: 4932-4939.
42. Weening, J. J., V. D. D'Agati, M. M. Schwartz, S. V. Seshan, C. E. Alpers, G. B. Appel, J. E. Balow, J. A. Bruijn, T. Cook, F. Ferrario, et al. 2004. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J. Am. Soc. Nephrol. 15: 241-250.
43. Akilesh, S., D. J. Shaffer, and D. Roopenian. 2003. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. Genome Res. 13: 1719-1727.
44. Leonard, W. J., R. Zeng, and R. Spolski. 2008. Interleukin 21: a cytokine/ cytokine receptor system that has come of age. J. Leukoc. Biol. 84: 348-356.
45. Lu, K. T., Y. Kanno, J. L. Cannons, R. Handon, P. Bible, A. G. Elkahloun, S. M. Anderson, L. Wei, H. Sun, J. J. O'Shea, and P. L. Schwartzberg. 2011. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity 35: 622-632.
46. Spolski, R., H. P. Kim, W. Zhu, D. E. Levy, and W. J. Leonard. 2009. IL-21 mediates suppressive effects via its induction of IL-10. J. Immunol. 182: 2859-2867.
47. Spolski, R., and W. J. Leonard. 2010. IL-21 is an immune activator that also mediates suppression via IL-10. Crit. Rev. Immunol. 30: 559-570.